Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?
| Published in: | The Innovation |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-07-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666675823000899 |